BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) announced a monthly dividend on Friday, January 2nd. Investors of record on Tuesday, January 20th will be paid a dividend of 0.2607 per share on Friday, January 30th. This represents a c) dividend on an annualized basis and a yield of 21.1%. The ex-dividend date of this dividend is Tuesday, January 20th.
BlackRock Capital Allocation Term Trust Stock Performance
BCAT stock opened at $14.82 on Friday. The firm’s fifty day moving average is $14.36 and its 200 day moving average is $14.69. BlackRock Capital Allocation Term Trust has a one year low of $12.91 and a one year high of $15.91.
Institutional Investors Weigh In On BlackRock Capital Allocation Term Trust
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. AdvisorNet Financial Inc raised its holdings in shares of BlackRock Capital Allocation Term Trust by 83.3% during the 2nd quarter. AdvisorNet Financial Inc now owns 1,947 shares of the company’s stock worth $29,000 after acquiring an additional 885 shares during the period. Keener Financial Planning LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust in the 3rd quarter valued at approximately $29,000. Geneos Wealth Management Inc. lifted its holdings in shares of BlackRock Capital Allocation Term Trust by 341.7% in the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after acquiring an additional 1,582 shares during the last quarter. Red Tortoise LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust during the 2nd quarter worth approximately $33,000. Finally, McIlrath & Eck LLC boosted its position in shares of BlackRock Capital Allocation Term Trust by 971.1% during the 3rd quarter. McIlrath & Eck LLC now owns 2,999 shares of the company’s stock worth $44,000 after purchasing an additional 2,719 shares during the period. Hedge funds and other institutional investors own 36.12% of the company’s stock.
About BlackRock Capital Allocation Term Trust
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
Featured Articles
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
